QL
DGX icon

Quarry LP’s Quest Diagnostics DGX Stock Holding History

Quarry LP’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.48K Sell
40
-20
-33% -$3.92K ﹤0.01% 967
2026
Q1 		$11.8K Sell
60
-584
-91% -$113K ﹤0.01% 877
2025
Q4 		$112K Buy
644
+365
+131% +$66.5K 0.02% 406
2025
Q3 		$53.2K Buy
279
+170
+156% +$30.2K 0.01% 809
2025
Q2 		$19.6K Sell
109
-358
-77% -$62.2K ﹤0.01% 1191
2025
Q1 		$79K Sell
467
-738
-61% -$121K 0.02% 613
2024
Q4 		$182K Buy
1,205
+826
+218% +$128K 0.03% 271
2024
Q3 		$58.8K Sell
379
-162
-30% -$24.2K 0.01% 647
2024
Q2 		$74.1K Buy
+541
New +$74.1K 0.02% 471
2024
Q1 		– Sell
-224
Closed -$30.9K – 1698
2023
Q4 		$30.9K Buy
224
+51
+29% +$6.71K ﹤0.01% 526
2023
Q3 		$21.1K Buy
+173
New +$23.1K ﹤0.01% 665

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Quarry LP's DGX Position: Q2 2026 in Review

Quarry LP reduced its Quest Diagnostics (DGX) stake by 33% in Q2 2026, selling an estimated $3.92K and leaving 40 shares worth $8.48K. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Quarry LP first reported a position in DGX in Q3 2023 and has held it in 11 quarters since. The position peaked at $182K in Q4 2024. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Quarry LP held 40 shares of Quest Diagnostics worth $8.48K as of Q2 2026.
  • Quarry LP sold 20 Quest Diagnostics shares in Q2 2026, an estimated $3.92K.
  • Quest Diagnostics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #967 holding.
  • Quarry LP first reported a position in Quest Diagnostics in Q3 2023 and has held it in 11 quarters since.
  • Quarry LP's Quest Diagnostics position peaked at $182K in Q4 2024.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.